Market Place
Sourcing Support
Dr. Neil Marwah Joins Pharmazz Inc. As President
11 Sep 2024 //
GLOBENEWSWIRE
Surge in pharma funding observed in August 2024, reached $135 mn
06 Sep 2024 //
EXPRESSPHARMA
Sun Pharma To Invest Up To $15M In Pharmazz
21 Aug 2024 //
GLOBENEWSWIRE
Pharmazz & Dr. Reddy`s have entered into a lice agreement to market Centhaquine
22 Mar 2024 //
PRESS RELEASE
A Special Protocol Assessment Agreement Reached with FDA for Ph 3 of Sovateltide
02 Oct 2023 //
GLOBENEWSWIRE
Sun Pharma and Pharmazz ink agreement for introducing Tyvalzi in India
15 Sep 2023 //
INDIAN PHARMA POST
Pharmazz, Inc. Announces Marketing Approval of Sovateltide in India
31 May 2023 //
GLOBENEWSWIRE
Pharmazz Announces Publications Regarding the Role of Adrenergic Receptors
20 Mar 2023 //
GLOBENEWSWIRE
EndoStream Announces Patient Enrolled in Trial for Nautilus Intrasaccular System
13 Feb 2023 //
PR NEWSWIRE
Pharmazz Announces US FDA Clearance for a PhIII Clinical Trial of Sovateltide
13 Feb 2023 //
PR NEWSWIRE
Clinical PIII Trial Results Demonstrating Sovateltide`s Efficacy
10 Feb 2023 //
PR NEWSWIRE
Pharmazz Presents Results of PIII Trial Demonstrating Sovateltide’s Efficacy
31 Oct 2022 //
GLOBENEWSWIRE
Pharmazz to Present on Sovateltide as a Treatment for Ischemic Stroke
26 Oct 2022 //
GLOBENEWSWIRE
Pharmazz Inc. Presents Data From its Positive Phase III Study of Centhaquine
13 Sep 2022 //
GLOBENEWSWIRE
Pharmazz announces Indian (CDSCO) Clearance of IND to a Phase 2 sovateltide
29 Aug 2022 //
GLOBENEWSWIRE
Pharmazz Announces Positive Results of PIII Trial Evaluating Sovateltide
25 May 2022 //
GLOBENEWSWIRE
Pharmazz says FDA clearance of IND application for a P II trial of centhaquine
10 Mar 2022 //
GLOBENEWSWIRE
Pharmazz Completes Enrollment of Phase III Trial Evaluating Sovateltide
17 Feb 2022 //
GLOBENEWSWIRE
Pharmazz submits IND to CDSCO for Phase II trial of sovateltide (PMZ-1620)
03 Feb 2022 //
GLOBENEWSWIRE
Sovateltide (PMZ-1620), shows promise in Alzheimer`s disease in patients
10 Jun 2021 //
PRNEWSWIRE
Lyfaquin®, a resuscitative agent marketed in India, shows new data
03 May 2021 //
PRNEWSWIRE
Marketing authorization received for Lyfaquin™ (centhaquine)
14 May 2020 //
PRNEWSWIRE
Centhaquine can provide hemodynamic stability, improve tissue oxygenation
09 Apr 2020 //
PR NEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.